InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Harsch Mutya, Directrice Juridique et GC. Insider active across 1 company, notably VYNE Therapeutics Inc.. Cumulatively, 27 filings have been logged. Split: 1 buy · 0 sell. Total volume traded: €23k. History available since 30 June 2021. The latest transaction was filed on 23 July 2026 (Retenue fiscale). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Harsch Mutya
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations27 total
22,516 shares@ US$0.89760.065% mcap15.3% of flowCommon StockSEC:0001727809-26-000008:0
4,007 shares@ US$0.59752.0% of flowCommon StockSEC:0001727809-26-000004:0
3,579 shares@ US$0.58011.8% of flowCommon StockSEC:0001727809-26-000002:0
3,581 shares@ US$0.3351.1% of flowCommon StockSEC:0001727809-25-000003:0
3,581 shares@ US$1.655.3% of flowCommon StockSEC:0001415889-25-019057:0
1,145 shares@ US$0.810.9% of flowCommon StockSEC:0001415889-25-015383:0
8,828 shares@ US$1.5812.8% of flowCommon StockSEC:0001415889-25-009631:0
4,697 shares@ US$3.3515.0% of flowCommon StockSEC:0001415889-25-000154:0
105 shares@ US$1.880.2% of flowCommon StockSEC:0001415889-24-024381:0
143 shares@ US$1.920.3% of flowCommon StockSEC:0001415889-24-019174:0
161 shares@ US$3.080.5% of flowCommon StockSEC:0001415889-24-010067:0
62,500 shares0Common StockSEC:0001209191-24-000467:0
62,500 shares0Common StockSEC:0001209191-23-058817:0
1,154 shares@ US$3.834.2% of flowCommon StockSEC:0001209191-23-051944:0
157 shares@ US$4.100.6% of flowCommon StockSEC:0001209191-23-041107:0
3,664 shares@ US$3.456311.7% of flowCommon StockSEC:0001209191-23-033802:0
478 shares@ US$3.081.3% of flowCommon StockSEC:0001209191-23-022798:0
10,000 shares@ US$2.5023.2% of flowCommon StockSEC:0001209191-23-020477:0
Canonical exit: 18 Jun 2023 (T+90)
1,813 shares@ US$0.150.3% of flowCommon StockSEC:0001209191-23-001111:0
1,813 shares@ US$0.2230.4% of flowCommon StockSEC:0001209191-22-052353:0
1,813 shares@ US$0.3890.7% of flowCommon StockSEC:0001209191-22-040783:0
3,630 shares@ US$0.651.8% of flowCommon StockSEC:0001209191-22-022526:0
75,000 shares0Common StockSEC:0001209191-22-020065:0
1,484 shares@ US$1.021.2% of flowCommon StockSEC:0001209191-22-000855:0
1,484 shares@ US$1.391.5% of flowCommon StockSEC:0001209191-21-058516:0
25 of 27 declarations
About Harsch Mutya
Harsch Mutya is Directrice Juridique et GC at VYNE Therapeutics Inc. The 26 filings recorded, all within the sampled set, cover the period from 2021-07-02 to 2026-04-02, with purchases totaling EUR 23411 and no sales; the most common transaction nature is Retenue fiscale.
